Results 61 to 70 of about 16,650 (226)
ABSTRACT Background Myasthenia gravis (MG) is a rare disorder characterized by fluctuating muscle weakness with potential life‐threatening crises. Timely interventions may be delayed by limited access to care and fragmented documentation. Our objective was to develop predictive algorithms for MG deterioration using multimodal telemedicine data ...
Maike Stein +7 more
wiley +1 more source
Paraneoplastic Mononeuritis Multiplex as a Presenting Feature of Adenocarcinoma of the Lung
Paraneoplastic neurologic syndromes are observed in less than 0.1% of cancer patients. Neurologic syndromes in lung cancer include Lambert-Eaton myasthenic syndrome, polyneuropathy, cerebellar degeneration, and rarely mononeuritis multiplex. In this case,
Esra Ekiz +2 more
doaj +1 more source
Presynaptic Congenital Myasthenic Syndrome 6 [PDF]
National Cancer Institute
openalex +1 more source
This article describes an occasion from expert practice of the department of dead bodies’ expert examinations and the department of complex expert examinations of the myasthenic syndrome that was lifelong unidentified because of the absence of distinct clinical symptoms.
N. G. Volkova +4 more
openaire +1 more source
Using Intravenous Inmunoglobulin in an Atypical Case of Lambert Eaton Síndrome.
A 48 year-old hypertensive, smoker patient who started presenting a generalized weakness, pait instability,visual disorders and uncontrolled blood pressure is presented. At physical examination quadriparesis and weakness extraocular muscles were found. A
Erélido Hernández Valero +1 more
doaj +2 more sources
ABSTRACT A 55‐year‐old male developed POLG‐related ophthalmoplegia in 2015 and was misdiagnosed with seronegative myasthenia gravis for 10 years. Whole‐genome sequencing identified compound heterozygous POLG mutations, highlighting its value in diagnosing refractory neuromuscular disorders.
Tanli Lu +3 more
wiley +1 more source
PharmVar GeneFocus: NAT2—Genetic Variation and Updated Nomenclature
The Pharmacogene Variation Consortium (PharmVar) provides nomenclature for the highly polymorphic human N‐acetyltransferase 2 (NAT2) gene. NAT2 metabolizes several clinically used drugs including isoniazid, hydralazine, amifampridine, procainamide, and sulfonamides such as dapsone, and also some highly carcinogenic arylamines.
Georgia Papanikolaou +14 more
wiley +1 more source
Myasthenia gravis associated with extrathymic malignancies is a rarely diagnosed pathology in clinical practice. We report a case of myasthenia gravis-like syndrome associated with small cell lung cancer.
R. Bunevičiūtė +2 more
doaj +1 more source
Sabine Lindquist, Martin StangelSection Clinical Neuroimmunology and Neurochemistry, Department of Neurology, Hannover Medical School, Hannover, GermanyAbstract: In Lambert–Eaton myasthenic syndrome (LEMS), antibodies against presynaptic ...
Lindquist S, Stangel M
doaj
Paraneoplastic neuromuscular syndromes at the outpatient level
Objective: to develop tactics for the differential diagnosis of paraneoplastic neuromuscular syndromes in patients at the outpatient level.Materials and methods: the study included 50 patients with classical neuromuscular paraneoplastic syndromes ...
A. E. Chertousova, I. V. Chernikova
doaj +1 more source

